These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1249 related articles for article (PubMed ID: 33178522)

  • 21. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
    Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
    J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic.
    Mahroum N; Watad A; Bridgewood C; Mansour M; Nasr A; Hussein A; Khamisy-Farah R; Farah R; Gendelman O; Lidar M; Shoenfeld Y; Amital H; Kong JD; Wu J; Bragazzi NL; McGonagle D
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19).
    Chen CX; Hu F; Wei J; Yuan LT; Wen TM; Gale RP; Liang Y
    Leukemia; 2021 Jun; 35(6):1661-1670. PubMed ID: 34002026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
    Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
    Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocilizumab for giant cell arteritis.
    Antonio AA; Santos RN; Abariga SA
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013484. PubMed ID: 35560150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocilizumab for giant cell arteritis.
    Antonio AA; Santos RN; Abariga SA
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013484. PubMed ID: 34420204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis.
    Rezaei S; Fatemi B; Karimi Majd Z; Minaei H; Peikanpour M; Anjidani N; Taheri A; Dastan F; Mosaed R
    Expert Rev Clin Immunol; 2021 May; 17(5):499-511. PubMed ID: 33823733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials.
    Ghaempanah F; Nikouei M; Cheraghi M; Jahangiri A; Moradi Y
    J Pharm Policy Pract; 2023 Nov; 16(1):151. PubMed ID: 37986199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials.
    Lin WT; Hung SH; Lai CC; Wang CY; Chen CH
    Int Immunopharmacol; 2021 Jul; 96():107602. PubMed ID: 33812260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis.
    Keske Ş; Akyol M; Tanrıöver C; Özlüşen B; Akcan RE; Güler U; Sait B; Kaçmaz B; Gönen M; Ergönül Ö
    Infection; 2023 Dec; 51(6):1619-1628. PubMed ID: 37162716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic Mesh Placement for the Prevention of Incisional Hernia in High-Risk Patients After Abdominal Surgery: A Systematic Review and Meta-Analysis.
    Ahmed J; Hasnain N; Fatima I; Malik F; Chaudhary MA; Ahmad J; Malik M; Malik L; Osama M; Baig MZ; Khosa F; Bhora F
    Cureus; 2020 Sep; 12(9):e10491. PubMed ID: 32953367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.